Remedium Lifecare [REMLIFE] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Remedium Lifecare Ltd.

BSE
Loading...

Sun Pharmaceutical Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Remedium Lifecare Ltd. wins in 6 metrics, Sun Pharmaceutical Industries Ltd. wins in 13 metrics, with 0 ties. Sun Pharmaceutical Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Remedium Lifecare Ltd. Sun Pharmaceutical Industries Ltd. Better
P/E Ratio (TTM) 6.54 36.73 Remedium Lifecare Ltd.
Price-to-Book Ratio 0.71 5.15 Remedium Lifecare Ltd.
Debt-to-Equity Ratio 1,033.81 6.68 Sun Pharmaceutical Industries Ltd.
PEG Ratio 0.03 3.59 Remedium Lifecare Ltd.
EV/EBITDA 206.57 23.61 Sun Pharmaceutical Industries Ltd.
Profit Margin (TTM) 2.33% 19.21% Sun Pharmaceutical Industries Ltd.
Operating Margin (TTM) 6.64% 26.17% Sun Pharmaceutical Industries Ltd.
EBITDA Margin (TTM) 6.64% 26.17% Sun Pharmaceutical Industries Ltd.
Return on Equity 16.22% 15.08% Remedium Lifecare Ltd.
Return on Assets (TTM) 0.19% 11.87% Sun Pharmaceutical Industries Ltd.
Free Cash Flow (TTM) $-11.44B $119.44B Sun Pharmaceutical Industries Ltd.
Dividend Yield N/A 0.97% N/A
1-Year Return -78.03% 7.25% Sun Pharmaceutical Industries Ltd.
Price-to-Sales Ratio (TTM) 0.14 7.05 Remedium Lifecare Ltd.
Enterprise Value $11.62B $3,783.37B Sun Pharmaceutical Industries Ltd.
EV/Revenue Ratio 2.21 6.66 Remedium Lifecare Ltd.
Gross Profit Margin (TTM) 9.53% 80.96% Sun Pharmaceutical Industries Ltd.
Revenue per Share (TTM) $8 $237 Sun Pharmaceutical Industries Ltd.
Earnings per Share (Diluted) $0.13 $45.46 Sun Pharmaceutical Industries Ltd.
Beta (Stock Volatility) 1.04 0.11 Sun Pharmaceutical Industries Ltd.

Remedium Lifecare Ltd. vs Sun Pharmaceutical Industries Ltd. Stock Performance Analysis

Loading Price Chart...

REMLIFE
SUNPHARMA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Remedium Lifecare Ltd.-2.78%-5.41%-20.45%-30.00%-65.35%-53.33%
Sun Pharmaceutical Industries Ltd.0.12%-1.06%-2.38%1.69%-2.10%3.43%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Remedium Lifecare Ltd.-78.03%-97.95%-55.81%245.45%245.45%245.45%
Sun Pharmaceutical Industries Ltd.7.25%79.99%166.96%144.01%669.48%2,278.32%

Performance & Financial Health Analysis: Remedium Lifecare Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricREMLIFESUNPHARMA
Market Information
Market Cap i₹308.70M₹3.88T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i13,880,4893,903,142
90 Day Avg. Volume i13,121,8133,253,866
Last Close₹0.35₹1,782.20
52 Week Range₹0.32 - ₹1.80₹1,548.00 - ₹1,916.60
% from 52W High-80.56%-7.01%
All-Time High₹4,547.80 (Jul 03, 2023)₹1,960.35 (Sep 30, 2024)
% from All-Time High-99.99%-9.09%
Growth Metrics
Quarterly Revenue Growth3.43%0.14%
Quarterly Earnings Growth3.86%0.16%
Financial Health
Profit Margin (TTM) i0.02%0.19%
Operating Margin (TTM) i0.07%0.26%
Return on Equity (TTM) i0.16%0.15%
Debt to Equity (MRQ) i1,033.816.68
Cash & Liquidity
Book Value per Share (MRQ)₹1.19₹324.46
Cash per Share (MRQ)₹0.02₹115.87
Operating Cash Flow (TTM) i₹-9,983,884,288₹110.84B
Levered Free Cash Flow (TTM) i₹-9,656,687,616₹109.29B
Dividends
Last 12-Month Dividend Yield iN/A0.97%
Last 12-Month Dividend iN/A₹16.50

Valuation & Enterprise Metrics Analysis: Remedium Lifecare Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricREMLIFE (Mar 24, 2026)SUNPHARMA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i6.5436.73
Forward P/E iN/A29.48
PEG Ratio i0.033.59
Price to Sales (TTM) i0.147.05
Price to Book (MRQ) i0.715.15
Market Capitalization
Market Capitalization i₹308.70M₹3.88T
Enterprise Value i₹11.62B₹3.78T
Enterprise Value Metrics
Enterprise to Revenue i2.216.66
Enterprise to EBITDA i206.5723.61
Risk & Other Metrics
Beta i1.040.11
Book Value per Share (MRQ) i₹1.19₹324.46

Financial Statements Comparison: Remedium Lifecare Ltd. vs Sun Pharmaceutical Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricREMLIFE (2025)SUNPHARMA (2025)
Revenue/Sales i4.05B520.41B
Cost of Goods Sold i3.98B121.98B
COGS % of Revenue i98.2%23.4%
Gross Profit i71.16M398.44B
Gross Margin i1.8%76.6%
Research & Development iN/AN/A
Operating Income (EBIT) i12.30M125.81B
Operating Margin i0.3%24.2%
EBITDA i120.41M167.25B
EBITDA Margin i3.0%32.1%
Pre-Tax Income i43.84M137.52B
Pre-Tax Income % of Revenue i1.1%26.4%
Income Tax i22.55M27.72B
Income Tax % of Revenue i0.6%5.3%
Net Income (Profit) i21.29M109.65B
Profit Margin i0.5%21.1%

Balance Sheet & Liquidity Metrics

MetricREMLIFE (2025)SUNPHARMA (2025)
Cash & Equivalents i2.82M102.69B
Total Current Assets i17.20B526.24B
Total Current Assets % of Revenue i424.5%101.1%
Total Current Liabilities i16.76B181.94B
Total Current Liabilities % of Revenue i413.7%35.0%
Long-Term Debt i03.58B
Long-Term Debt % of Revenue i0.0%0.7%
Total Shareholders Equity i438.91M724.86B
Retained Earnings i35.71M578.62B
Retained Earnings % of Revenue i0.9%111.2%
Property, Plant & Equipment i83,000100.36B

Cash Flow Statement Comparison

MetricREMLIFE (2025)SUNPHARMA (2025)
Operating Cash Flow i-16.38B110.84B
Operating Cash Flow % of Revenue i-404.2%21.3%
Capital Expenditures iN/A-20.68B
Free Cash Flow i-11.44B119.44B
FCF Margin i-282.4%23.0%
Debt Repayment iN/A-43.44B
Common Stock Repurchase iN/A-29.00B

Short Interest & Institutional Ownership Analysis

MetricREMLIFESUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i881.99M2.40B
Float Shares i382.00M1.07B
% Held by Insiders i15.76%55.62%
% Held by Institutions i0.00%28.69%
% Held by Public i84.24%15.69%

Dividend Analysis & Yield Comparison: Remedium Lifecare Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricREMLIFESUNPHARMA
Last 12-Month Dividend iN/A₹16.50
Last 12-Month Dividend Yield iN/A0.97%
3-Year Avg Annual Dividend iN/A₹17.33
3-Year Avg Dividend Yield iN/A0.51%
3-Year Total Dividends iN/A₹52.00
Ex-Dividend DateN/AFeb 05, 2026